Search filters

List of works by Amanda Cashen

10-day decitabine schedule in acute myeloid leukaemia: no extra bang for the buck

scientific article published on 10 December 2018

18F-FDG PET/CT for early response assessment in diffuse large B-cell lymphoma: poor predictive value of international harmonization project interpretation

scientific article

A Phase II Multicenter Study of the Addition of Azacitidine to Reduced-Intensity Conditioning Allogeneic Transplant for High-Risk Myelodysplasia (and Older Patients with Acute Myeloid Leukemia): Results of CALGB 100801 (Alliance)

scientific article published on 15 June 2019

A cytogenetic model predicts relapse risk and survival in patients with acute myeloid leukemia undergoing hematopoietic stem cell transplantation in morphologic complete remission

scientific article published on 20 November 2014

A phase 1 study of concomitant high-dose lenalidomide and 5-azacitidine induction in the treatment of AML

scientific article published on 25 July 2012

A phase 1/2 study of chemosensitization with the CXCR4 antagonist plerixafor in relapsed or refractory acute myeloid leukemia

scientific article

A phase 2 multicenter study of lenalidomide in relapsed or refractory classical Hodgkin lymphoma

scientific article

A phase 2 study of high-dose lenalidomide as initial therapy for older patients with acute myeloid leukemia

scientific article

A phase I dose escalation study of oral bexarotene in combination with intravenous decitabine in patients with AML.

scientific article

A phase I study of carfilzomib for relapsed or refractory acute myeloid and acute lymphoblastic leukemia

scientific article published on 05 October 2015

A phase II study of 5-day intravenous azacitidine in patients with myelodysplastic syndromes.

scientific article published in September 2009

A phase II study of V-BEAM as conditioning regimen before second auto-SCT for multiple myeloma

scientific article published on 28 July 2014

A phase II study of plerixafor (AMD3100) plus G-CSF for autologous hematopoietic progenitor cell mobilization in patients with Hodgkin lymphoma

scientific article

A pilot study of lenalidomide maintenance therapy after autologous transplantation in relapsed or refractory classical Hodgkin lymphoma

scientific article published on 20 August 2020

A prognostic model predicting autologous transplantation outcomes in children, adolescents and young adults with Hodgkin lymphoma

scientific article

A study of high-dose lenalidomide induction and low-dose lenalidomide maintenance therapy for patients with hypomethylating agent refractory myelodysplastic syndrome.

scientific article published on 27 April 2016

AMD3100: CXCR4 antagonist and rapid stem cell-mobilizing agent

scientific article

Allo-SCT conditioning for myelodysplastic syndrome and acute myeloid leukemia with clofarabine, cytarabine and ATG.

scientific article

Allogeneic haematopoietic cell transplantation for extranodal natural killer/T-cell lymphoma, nasal type: a CIBMTR analysis

scientific article published on 2 August 2017

Allogeneic hematopoietic stem cell transplantation in Hodgkin lymphoma: a systematic review and meta-analysis

scientific article published on 04 January 2016

An international confirmatory study of the prognostic value of early PET/CT in diffuse large B-cell lymphoma: comparison between Deauville criteria and ΔSUVmax.

scientific article published on 7 May 2013

Assessment of cellular proliferation in tumors by PET using 18F-ISO-1.

scientific article published on 28 January 2013

Autologous or reduced-intensity conditioning allogeneic hematopoietic cell transplantation for chemotherapy-sensitive mantle-cell lymphoma: analysis of transplantation timing and modality

scientific article published on 16 December 2013

Belinostat for the treatment of relapsed or refractory peripheral T-cell lymphoma

scientific article published on January 2015

Bortezomib, Bendamustine, and Rituximab in Patients With Relapsed or Refractory Follicular Lymphoma: The Phase II VERTICAL Study ⬇️

scientific article published on September 1, 2011

CAR-modified memory-like NK cells exhibit potent responses to NK-resistant lymphomas

scientific article published on 02 July 2020

Cellular stressors contribute to the expansion of hematopoietic clones of varying leukemic potential

scientific article published on 31 January 2018

Chemotherapy versus Hypomethylating Agents for the Treatment of Relapsed Acute Myeloid Leukemia and Myelodysplastic Syndrome after Allogeneic Stem Cell Transplant.

scientific article published on 26 March 2016

Combination decitabine, arsenic trioxide, and ascorbic acid for the treatment of myelodysplastic syndrome and acute myeloid leukemia: a phase I study.

scientific article published on 3 August 2011

Comparative effectiveness of anthracycline-containing chemotherapy in United States veterans age 80 and older with diffuse large B-cell lymphoma.

scientific article

Comparison of Outcomes after Peripheral Blood Haploidentical versus Matched Unrelated Donor Allogeneic Hematopoietic Cell Transplantation in Patients with Acute Myeloid Leukemia: A Retrospective Single-Center Review

scientific article published on 17 May 2016

Cytogenetic patterns of relapse following allogeneic stem cell transplantation in morphologic complete remission in patients with acute myeloid leukemia

scientific article published on 20 March 2015

Cytokines and stem cell mobilization for autologous and allogeneic transplantation.

scientific article published in November 2004

Decitabine in the treatment of acute myeloid leukemia in elderly patients

scientific article published on 03 February 2014

Does early imatinib-induced myelosuppression predict hematologic responses in patients with advanced-phase chronic myeloid leukemia?

scientific article published in November 2003

Dynamic changes in the clonal structure of MDS and AML in response to epigenetic therapy

scientific article published on 14 October 2016

Early failure of frontline rituximab-containing chemo-immunotherapy in diffuse large B cell lymphoma does not predict futility of autologous hematopoietic cell transplantation

scientific article

Early post-transplant contrast-enhanced abdominopelvic CT scan predicts the risk of subsequent acute GvHD.

scientific article published on 5 October 2015

Enhancer sequence variants and transcription-factor deregulation synergize to construct pathogenic regulatory circuits in B-cell lymphoma

scientific article

Extended retreatment with brentuximab vedotin (SGN-35) maintains complete remission in patient with recurrent systemic anaplastic large-cell lymphoma

scientific article published on 10 October 2011

Fifty Shades of GATA2 Mutation: A Case of Plasmablastic Lymphoma, Nontuberculous Mycobacterial Infection, and Myelodysplastic Syndrome

scientific article published on 29 May 2019

First-in-human Phase 1 Clinical Study of the IL-15 Superagonist Complex ALT-803 to Treat Relapse after Transplantation

scientific article published on 20 February 2018

Graft-Versus-Lymphoma Effect Can Be Rapid and Potent in Diffuse Large B-Cell Lymphoma

scientific article published in August 2016

HLA disparity is not inconsequential in peripheral blood T-replete haploidentical hematopoietic stem cell transplantation

scientific article published on 9 May 2016

Hematologic Recovery after Pretransplant Chemotherapy Does Not Influence Survival after Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia Patients

scientific article published on 31 March 2015

High dose therapy and autologous hematopoietic stem cell transplantation in septuagenarians with non-Hodgkin lymphoma: Feasible, but for which patients?

scientific article

High resolution array comparative genomic hybridization identifies copy number alterations in diffuse large B-cell lymphoma that predict response to immuno-chemotherapy ⬇️

scientific article published on March 1, 2011

Ibrutinib-Rituximab or Chemoimmunotherapy for Chronic Lymphocytic Leukemia

scientific article published on 01 August 2019

Immunophenotypic Variations in Mantle Cell Lymphoma and Their Impact on Clinical Behavior and Outcome

scientific article published on 05 June 2018

Impact of Pretransplantation (18)F-fluorodeoxy Glucose-Positron Emission Tomography Status on Outcomes after Allogeneic Hematopoietic Cell Transplantation for Non-Hodgkin Lymphoma

scientific article

Impact of mobilization and remobilization strategies on achieving sufficient stem cell yields for autologous transplantation.

scientific article published in September 2008

Implication of Rituximab Infusion Reactions on Clinical Outcomes in Patients With Diffuse Large B-cell Lymphoma: A Single Institution Experience

scientific article published on 30 September 2019

Lack of a Prognostic Impact of the MyD88 L265P Mutation for Diffuse Large B Cell Lymphoma Patients Undergoing Autologous Stem Cell Transplantation.

scientific article published on 25 August 2017

Late cardiac events and their impact on overall survival in patients receiving an allogeneic stem cell transplant.

scientific article published on 02 June 2021

Leukostasis in adult acute hyperleukocytic leukemia: a clinician's digest

scientific article published on 27 March 2016

Longitudinal Body Composition Changes in Diffuse Large B-cell Lymphoma Survivors: A Retrospective Cohort Study of United States Veterans

scientific article published on 5 July 2016

Loss of synergistic transcriptional feedback loops drives diverse B-cell cancers

scientific article published on 27 August 2021

Maintenance Therapy with Decitabine after Allogeneic Stem Cell Transplantation for Acute Myelogenous Leukemia and Myelodysplastic Syndrome

scientific article

Minimal activity of nanoparticle albumin-bound (nab) paclitaxel in relapsed or refractory lymphomas: results of a phase-I study

scientific article

Mixed Donor Chimerism Following Simultaneous Pancreas-Kidney Transplant

scientific article published on 28 June 2017

Mobilization of allogeneic peripheral blood stem cell donors with intravenous plerixafor mobilizes a unique graft

scientific article published on 14 March 2017

Mobilizing stem cells from normal donors: is it possible to improve upon G-CSF?

scientific article published on 19 March 2007

Multicenter Analysis of Advanced Stage Grade 3A Follicular Lymphoma Outcomes by Frontline Treatment Regimen

scientific article published on 12 November 2018

Multicenter, phase II study of decitabine for the first-line treatment of older patients with acute myeloid leukemia

scientific article

Multidimensional analyses of donor memory-like NK cells reveal new associations with response after adoptive immunotherapy for leukemia

scientific article published on 21 August 2020

Mutational landscape and response are conserved in peripheral blood of AML and MDS patients during decitabine therapy

scientific article published on 12 January 2017

NKG2D-NKG2D Ligand Interaction Inhibits the Outgrowth of Naturally Arising Low-Grade B Cell Lymphoma In Vivo

scientific article published on 2 May 2016

Oral valganciclovir versus ganciclovir as delayed pre-emptive therapy for patients after allogeneic hematopoietic stem cell transplant: a pilot trial (04-0274) and review of the literature.

scientific article published on 28 October 2011

Outcomes of allogeneic stem cell transplantation in hepatosplenic T-cell lymphoma

scientific article published on 5 June 2015

Outcomes of hematopoietic cell transplantation for diffuse large B cell lymphoma transformed from follicular lymphoma.

scientific article

Patterns of infectious complications in acute myeloid leukemia and myelodysplastic syndromes patients treated with 10-day decitabine regimen.

scientific article published on 23 October 2017

Peritransplant Serum Albumin Decline Predicts Subsequent Severe Acute Graft-versus-Host Disease after Mucotoxic Myeloablative Conditioning

scientific article published on 14 March 2016

Pharmacokinetics of decitabine administered as a 3-h infusion to patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS).

scientific article

Phase I study of azacitidine following donor lymphocyte infusion for relapsed acute myeloid leukemia post allogeneic stem cell transplantation.

scientific article published on 22 July 2016

Phase I study of cladribine, cytarabine, granulocyte colony stimulating factor (CLAG regimen) and midostaurin and all-trans retinoic acid in relapsed/refractory AML.

scientific article published on 2 February 2014

Phase I study of oral clofarabine consolidation in adults aged 60 and older with acute myeloid leukemia

scientific article

Phase I/II Study of Intravenous Plerixafor Added to a Mobilization Regimen of Granulocyte Colony-Stimulating Factor in Lymphoma Patients Undergoing Autologous Stem Cell Collection

scientific article published on 2 May 2017

Phase II Study of Propylene Glycol-Free Melphalan Combined with Carmustine, Etoposide, and Cytarabine for Myeloablative Conditioning in Lymphoma Patients Undergoing Autologous Stem Cell Transplantation

scientific article published on 26 August 2016

Phase II study of the histone deacetylase inhibitor belinostat (PXD101) for the treatment of myelodysplastic syndrome (MDS) ⬇️

scientific article published on May 3, 2011

Plerixafor hydrochloride: a novel agent for the mobilization of peripheral blood stem cells

scientific article published on July 2009

Plerixafor, a CXCR4 antagonist for the mobilization of hematopoietic stem cells

scientific article published in November 2008

Postrelapse survival in diffuse large B-cell lymphoma after therapy failure following autologous transplantation

scientific article published on 01 June 2019

Predictive factors and outcomes for ibrutinib therapy in relapsed/refractory mantle cell lymphoma-a "real world" study

scientific article published on 8 January 2017

Pretherapy metabolic tumour volume is an independent predictor of outcome in patients with diffuse large B-cell lymphoma

scientific article published on 6 June 2014

Prognostic significance of FDG-PET in relapsed or refractory classical Hodgkin lymphoma treated with standard salvage chemotherapy and autologous stem cell transplantation

scientific article

Prognostic significance of [18F]fluorodeoxyglucose-positron emission tomography in peripheral T-cell lymphoma treated with stem cell transplantation: a retrospective analysis

scientific article published on 16 May 2014

Progressive multifocal leukoencephalopathy in a patient with Hodgkin lymphoma treated with brentuximab vedotin

scientific article published on 23 April 2012

Proteasome inhibitors evoke latent tumor suppression programs in pro-B MLL leukemias through MLL-AF4

scientific article

Protective effect of cytomegalovirus reactivation on relapse after allogeneic hematopoietic cell transplantation in acute myeloid leukemia patients is influenced by conditioning regimen

scientific article

Protein losing enteropathy associated with follicular lymphoma of the small bowel.

scientific article published in April 2009

RB but not R-HCVAD is a feasible induction regimen prior to auto-HCT in frontline MCL: results of SWOG Study S1106.

scientific article published on 19 December 2016

Radioimmunotherapy-based conditioning for hematopoietic stem cell transplantation: Another step forward

scientific article published on 2 May 2016

Recurrent somatic mutations affecting B-cell receptor signaling pathway genes in follicular lymphoma.

scientific article

Results of a Prospective Randomized, Open-Label, Noninferiority Study of Tbo-Filgrastim (Granix) versus Filgrastim (Neupogen) in Combination with Plerixafor for Autologous Stem Cell Mobilization in Patients with Multiple Myeloma and Non-Hodgkin Lymp

scientific article published on 7 August 2017

Retrospective comparison of allogeneic vs autologous transplantation for diffuse large B-cell lymphoma with early relapse or primary induction failure

scientific article published on 22 September 2014

Rituximab/bendamustine and rituximab/cytarabine induction therapy for transplant-eligible mantle cell lymphoma

scientific article published on 01 March 2020

Safety and tolerability of idelalisib, lenalidomide, and rituximab in relapsed and refractory lymphoma: the Alliance for Clinical Trials in Oncology A051201 and A051202 phase 1 trials.

scientific article

Salvage regimens for Hodgkin lymphoma.

scientific article published on July 2008

Salvage therapy for acute myeloid leukemia with fludarabine, cytarabine, and idarubicin with or without gemtuzumab ozogamicin and with concurrent or sequential G-CSF.

scientific article published in November 2009

Second complete remission in an elderly patient with acute myeloid leukemia retreated with decitabine

scientific article published on 01 July 2006

Serendipity: decitabine monotherapy induced complete molecular response in a 77-year-old patient with acute promyelocytic leukemia

scholarly article by Ramzi Abboud et al published April 2019 in Haematologica

Standard-of-Care Axicabtagene Ciloleucel for Relapsed or Refractory Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium

scientific article published on 13 May 2020

TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes

scientific article

The IL-15-Based ALT-803 Complex Enhances FcγRIIIa-Triggered NK Cell Responses and In Vivo Clearance of B Cell Lymphomas

scientific article published on 30 September 2015

The phase 3 DUO trial: duvelisib versus ofatumumab in relapsed and refractory CLL/SLL ⬇️

scientific article published on 04 October 2018

Therapy in primary mediastinal B-cell lymphoma

scientific article published in July 2013

Therapy of relapsed Hodgkin lymphoma.

scientific article published on August 2007

Trends in postrelapse survival in classic Hodgkin lymphoma patients after experiencing therapy failure following auto-HCT

scientific article published on 01 January 2020

Use of recombinant factor VIIa for hip surgery in a patient with factor-VII deficiency. A case report

scientific article published in February 2007

Paulina is supported by:

About Paulina

Help